Prevalence, comorbidities, and treatment patterns of patients suffered from prurigo in Japan

Prevalence, comorbidities, and treatment patterns of patients suffered from prurigo in Japan - EPIPUS-J

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050273

Enrollment

4000

Registered

2023-02-08

Start date

2022-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prurigo

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study population consists of the patients diagnosed with prurigo or PN at dermatology in the JMDC Claims database, in 2005 to 2021 for cross-sectional study and in 2020 for retrospective cohort study

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
Annual prevalence of prurigo and PN are calculated by age and gender	—

Secondary

Measure	Time frame
Annual incidence rate of prurigo and PN are calculated by age and gender. Comorbidities, HCRU, and current treatment for prurigo and PN	—

Countries

Japan

Contacts

Public ContactTakuo Yoshida

Sanofi K.K. Dermatology Medical Immunology Medical Specialty Care

Sanofi_Medical@sanofi.com03-6301-4575

Outcome results